CAR-T therapy can be safely manufactured at hospital, finds ICMR-funded trial led by CMC Vellore
CART-T cell therapy, these cells are engineered to recognise and target the specific cancer cell, thus using the immune system to fight the disease. Photograph used for representational purposes only | Photo Credit: File Photo An ICMR-funded trial led by CMC Vellore demonstrated that CAR-T therapy, which uses a patient’s own T cells to fight … Read more